Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2025-12-27 @ 9:49 PM
Study NCT ID:
NCT00796250
Status:
TERMINATED
Last Update Posted:
2017-03-23
First Post:
2008-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2005-01-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-01-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-21
First Submit QC Date:
None
Study First Post Date:
2008-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-21
Last Update Post Date:
2017-03-23
Last Update Post Date Type:
ACTUAL